R
3.81
+8.24%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
$74.7m
FY2019FY2025
Net income
−$644.8m
FY2019FY2025
Free cash flow
−$378.3m
FY2019FY2025
Shareholders' equity
$1.13bn
FY2019FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Revenue | $74.7m | $58.8m | $43.9m | $39.7m | $10.0m | $3.4m | $1.7m |
| Research and development | $425.3m | $314.4m | $241.2m | $155.7m | $135.3m | $63.3m | $45.8m |
| Operating income | −$648.1m | −$479.0m | −$350.1m | −$245.7m | −$183.6m | −$86.0m | −$62.4m |
| Net income | −$644.8m | −$463.7m | −$328.1m | −$239.4m | −$178.1m | −$87.0m | −$62.5m |
| Diluted earnings per share | -1.22 | -1.38 | -1.41 | -1.29 | -1.05 | -0.52 | -2.84 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Total assets | $1.47bn | $1.45bn | $653.7m | $701.3m | $610.3m | $298.6m | $101.4m |
| Cash and short-term investments | $743.3m | $594.4m | $391.6m | $549.9m | $516.6m | $262.1m | $69.9m |
| Total liabilities | $343.3m | $413.8m | $190.3m | $215.5m | $67.4m | $504.9m | $225.7m |
| Debt | $31.3m | $27.4m | $1.1m | $600,000 | $700,000 | $12.5m | $12.5m |
| Shareholders' equity | $1.13bn | $1.03bn | $463.4m | $485.8m | $542.9m | −$206.3m | −$124.3m |
| Shares outstanding | 527m | 336m | 233m | 186m | 169m | 167m | 22m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Cash from operations | −$371.8m | −$359.2m | −$287.8m | −$83.5m | −$158.6m | −$45.4m | −$57.0m |
| Capital spending | −$6.5m | −$13.7m | −$12.0m | −$37.4m | −$39.8m | −$6.7m | −$3.9m |
| Free cash flow | −$378.3m | −$372.9m | −$299.7m | −$120.9m | −$198.4m | −$52.1m | −$61.0m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.7m | $6.5m | $35.5m | $5.2m | $19.1m | $14.7m | $4.5m | $26.1m |
| Operating income | −$135.0m | −$128.5m | −$108.3m | −$172.2m | −$176.2m | −$191.4m | −$183.8m | −$98.4m |
| Net income | −$131.0m | −$117.5m | −$108.1m | −$162.3m | −$171.9m | −$202.5m | −$178.9m | −$95.7m |
| Diluted earnings per share | -0.25 | -0.22 | -0.21 | -0.31 | -0.33 | -0.38 | -0.53 | -0.28 |
| Cash from operations | −$105.0m | −$81.0m | −$46.0m | −$117.0m | −$76.0m | −$131.0m | −$115.0m | −$59.0m |
| Capital spending | −$1.0m | — | −$1.0m | — | −$3.0m | −$1.0m | −$1.0m | −$4.0m |
| Free cash flow | −$106.0m | — | −$47.0m | — | −$79.0m | −$132.0m | −$116.0m | −$63.0m |
| Total assets | $1.21bn | $1.34bn | $1.47bn | $1.40bn | $1.30bn | $1.31bn | $1.45bn | $726.5m |
| Cash and short-term investments | $545.7m | $654.5m | $743.3m | $659.8m | $528.2m | $500.5m | $594.4m | $427.6m |
| Debt | $27.4m | $29.5m | $31.3m | $32.3m | $34.7m | $36.9m | $41.2m | $37.0m |
| Shareholders' equity | $915.0m | $1.02bn | $1.13bn | $1.05bn | $919.1m | $933.9m | $1.03bn | $524.6m |
Financial ratios
Data as of 31 Oct 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Operating margin | -861.1% | -787.3% | -756.7% | -619.3% | -1827.8% | -2509.4% |
| Net margin | -863.4% | -788.0% | -747.7% | -603.4% | -1780.7% | -2549.3% |
| Return on equity | -57.0% | -44.8% | -70.8% | -49.3% | -32.8% | 42.2% |
| Return on assets | -43.7% | -32.0% | -50.2% | -34.1% | -29.2% | -29.1% |
| Free cash flow yield | -17.2% | -25.5% | -29.4% | -6.2% | -17.4% | -5.7% |
| Revenue growth | 26.9% | 34.1% | 10.6% | 296.8% | 193.0% | 99.5% |
| Earnings growth | 39.1% | 41.3% | 37.0% | 34.5% | 104.7% | 39.2% |
| Current ratio | 5.50x | 3.81x | 4.70x | 5.68x | 11.46x | 11.53x |
| Debt to equity | 0.03x | 0.04x | 0.02x | 0.01x | 0.00x | -0.06x |
| Equity ratio | 76.7% | 71.4% | 70.9% | 69.3% | 89.0% | -69.1% |
| Interest coverage | -355.30x | -294.67x | -3423.00x | -4467.76x | -61.92x | -62.98x |
| R&D as a share of sales | 569.4% | 534.4% | 549.8% | 392.4% | 1352.7% | 1855.2% |
| Buybacks as a share of market value | -56.7% | -44.1% | -25.6% | -9.6% | -1.4% | -659.3% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 23.5% | 85.4% | — |
| Operating income | 38.2% | 49.8% | — |
| Net income | 39.1% | 49.3% | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Operating margin | -844.2% | -793.7% | -864.5% | — |
| Net margin | -830.2% | -772.0% | -842.1% | — |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Price to earnings | -3.3 | -4.9 | -7.0 | -6.0 | -16.3 |
| Price to sales | 28.9 | 38.6 | 52.4 | 36.1 | 290.1 |
Market value over time
30 Apr 2021 to 30 Oct 2026, in USD
$768.2m$2.15bn
Share price return
Finished calendar years
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Return | -29% | -38% | 32% | -61% | -38% |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.